An overview: Human polyomavirus JC virus and its associated disorders

Journal of NeuroVirology

Volumn 9, Issue SUPPL. 1, 2003, Pages 3-9

  Safak, Mahmut ^a   Khalili, Kamel ^a  

^a Temple University   (United States)

Author keywords

Cancer; Central nervous system; HIV 1; NeuroAIDS; Oncogene

Indexed keywords

ISOPROTEIN; STRUCTURAL PROTEIN; VIRUS DNA; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN; VIRUS SMALL T ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTROCYTE; BRAIN TUMOR; CYTOLYSIS; DEMYELINATING DISEASE; DISEASE ASSOCIATION; GENE FUNCTION; GENE STRUCTURE; GENOME ANALYSIS; HUMAN; IMMUNE DEFICIENCY; JC VIRUS; MEDULLOBLASTOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1; JC VIRUS; POLYOMAVIRUS;

EID: 0037799113     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390195360     Document Type: Review

References (67)

1. Alwine J (1982). Evidence for simian virus 40 late transcriptional control: mixed infection of wild-type simian virus 40 and a leader deletion mutant exhibit trans effects on late viral RNA synthesis. J Virol 37: 730-737.
2. Amemiya K, Traub R, Durham L, Major EO (1989). Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264: 7025-7032.
3. Astrom KE, Mancall EL, Richardson EP Jr (1958). Progressive multifocal encephalophathy: a hitherto unrecognized complication of chronic lymphocytic leukemia and lymphoma. Brain 81: 99-111.
4. Beggs AH, Frisque RJ, Scangos GA (1988). Extinction of JC virus tumor-antigen expression in glial cell-fibroblast hybrids. Proc Natl Acad Sci U S A 85: 7632-7636.
5. Beggs AH, Miner JH, Scangos GA (1990). Cell type-specific expression of JC virus T antigen in primary and established cell lines from transgenic mice. J Gen Virol 71: 151-164.
6. Berger JR, Concha M (1995). Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neuro Virol 1: 5-18.
7. Berger JR, Kaszovitz B, Post JD, Dickinson G (1987). Progressive multifocal encephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Int Med 107: 78-87.
8. Bollag B, Chuke WF, Frisque RJ (1989). Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J Virol 63: 863-872.
9. Brooks BR, Walker DL (1984). Progressive multifocal encephalopathy. Neurol Clin 2: 299-313.
10. Carswell S, Alwine JC (1986). Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J Virol 60: 1055-1061.
11. Carswell S, Resnick J, Alwine JC (1986). Construction and characterization of CV-1P cell lines which constitutively express the simian virus 40 Agnoprotein: alteration of plaquing phenotype of viral Agnoproteingene mutants. J Virol 60: 415-422.
12. Castoigna P, Rondot P, Escourolle R, Ribadeau-Dumas JL, Catala F, Hauw JJ (1974). Leukoencephalopathie multifocale progressive et "glomes" multiples. Rev Neurol 130: 379-392.
13. Chen NN, Chang CF, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili K (1995). Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci U S A 92: 1087-1091.
14. Chen NN, Khalili K (1995). Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69: 5843-5848.
15. Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K (1992). Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66: 7355-7361.
16. Cullen BR (1990). The HIV-1 Tat protein: as RNA specific processivity factor? Cell 63: 655-657.
17. Dyson N, Buchkovich KP, Whyte P, Harlow E (1989). The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255.
18. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990). Tat protein of HIV stimulates growth of Kaposi's sarcoma lesion of AIDS patients. Nature 345: 84-86.
19. Feigenbaum L, Hinrichs SH, Jay G (1992). JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virol 66: 1176-1182.
20. Feigenbaum L, Khalili K, Major EO, Khoury G (1987). Regulation of the host range of human papovavirus JCV. Proc Natl Acad Sci U S A 84: 3695-3698.
21. Frankel AD (1992). Activation of HIV transcription by Tat. Curr Opin Genes Dev 2: 293-298.
22. Frankel AD, Pabo CO (1988). Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55: 1189-1193.
23. Franks R, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL, Khalili K (1996). Formation of undifferentiated mesenteric tumors in transgenic mice expressing human neurotropic polyomavirus early protein. Oncogene 12: 2573-2578.
24. Frisque RJ (2001). Structure and function of JC virus T′ proteins. J Neuro Virol 7: 293-297.
25. Frisque RJ, Bream GL, Cannella MT (1984). Human polyomavirus JC virus genome. J Virol 51: 458-469.
26. Frisque RJ, White FA III (1992). The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. In: Molecular neurovirology. Roos RP (ed). Totowa, NJ: Humana Press, pp 25-158.
27. Genis P, Jett M, Bernton EV, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992). Cytokines and arachidonic metabolites produced during the human immunodeficiency virus (HIV)-infected macrophage-astroglia interaction: impications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703-1718.
28. Gordon J, Khalili K (1998). The human polyomavirus, JCV, and neurological diseases. Int J Mol Med 1: 647-655.
29. Haggerty S, Walker DL, Frisque RJ (1989). JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J Virol 63: 2180-2190.
30. Henson J, Saffer J, Furneaux H (1992). The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32: 72-77.
31. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A (1998). Retinoblastoma-related protein pRb2/p130 suppresses tumor growth in vivo. J Natl Cancer Inst 90: 1451-1460.
32. Kenney S, Natarajan V, Strike D, Khoury G, Salzman NP (1984). JC virus enhancer-promoter active in human brain cells. Science 226: 1337-1339.
33. Kerr D, Chang CF, Chen N, Gallia GL, Raj G, Schwartz B, Khalili K (1994). Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68: 7637-7643.
34. Khalili K, Feigenbaum L, Khoury G (1987). Evidence for a shift in 5′-termini of early viral RNA during the lytic cycle of JC virus. Virology 158: 469-472.
35. Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K (1999). Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci U S A 96: 11519-11524.
36. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR (1999). JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 96: 7484-7489.
37. L promoter by JCV and SV40 early proteins. Virology 170: 292-295.
38. London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T (1978). Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246-1249.
39. London WT, Houff SA, McKeever PE, Wallen WC, Sever JL, Padgett BL, Walker DL (1983). Viral-induced astrocytomas in squirrel monkeys. Prog Clin Biol Res 105: 227-237.
40. Lynch KJ, Frisque RJ (1990). Identification of critical elements within the JC virus DNA replication origin. J Virol 64: 5812-5822.
41. Lynch KJ, Frisque RJ (1991). Factors contributing to the restricted DNA replicating activity of JC virus. Virology 180: 306-317.
42. Lynch KJ, Haggerty S, Frisque RJ (1994). DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 204: 819-822.
43. Major EO, Amemiya K, Tornatore C, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49-73.
44. Margolskee RF, Nathans D (1983). Suppression of a VP1 mutant of simian virus 40 by missense mutations in serine codons of the viral Agnoproteingene. J Virol 48: 405-409.
45. Mertz JE, Murphy A, Barkan A (1983). Mutants deleted in the Agnoproteingene of simian virus 40 define a new complementation group. J Virol 48: 405-409.
46. Neel JV (1999). The Colonel Harlan D Sanders Award Address for 1998: JC virus and its possible role in oncogenesis. Am J Med Genet 83: 152-156.
47. Ng SC, Mertz JE, Sanden-Will S, Bina M (1985). Simian virus 40 maturation in cells harboring mutants deleted in the Agnoproteingene. J Biol Chem 260: 1127-1132.
48. Piatak M, Subramanian KN, Roy P, Weissman SM (1981). Messenger RNA production by viable simian virus 40 mutants with deletions in the leader regionz. J Mol Biol 153: 589-618.
49. Raj GV, Khalili K (1994). Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 14: 7770-7781.
50. Raj GV, Khalili K (1995). Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213: 283-291.
51. Ranganathan PN, Khalili K (1993). The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21: 1959-1964.
52. Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996). Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A 93: 7352-7357.
53. Renner K, Leger H, Wegner M (1994). The POU doamin protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc Natl Acad Sci U S A 91: 6433-6437.
54. Richardson EP (1961). Progressive multifocal encephalopathy. N Engl J Med 265: 815-823.
55. Safak M, Barruccco R, Darbinyan A, Okada Y, Nagashima K, Khalili K (2001). Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 75: 1476-1486.
56. Safak M, Gallia GL, Ansari SA, Khalili K (1999a). Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73: 10146-10157.
57. Safak M, Gallia GL, Khalili K (1999b). A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. Virology 262: 178-189.
58. Safak M, Gallia GL, Khalili K (1999c). Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCV·CY in glial cells. Mol Cell Biol 19: 2712-2723.
59. Safak M, Sadowska B, Barrucco R, Khalili K (2002). Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol 76: 3828-3838.
60. Small JA, Khoury G, Jay G, Howley PM, Scangos GA (1986b). Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. Proc Natl Acad Sci U S A 83: 8288-8292.
61. Small JA, Scangos GA, Cork L, Jay G, Khoury G (1986a). The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 46: 13-18.
62. Swenson JJ, Trowbridge PW, Frisque RJ (1996). Replication activity of JC virus large T antigen phophorylation and zinc finger domain mutants. J Neuro Virol 2: 78-86.
63. Tada H, Lashgari MS, Khalili K (1991). Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. Virology 180: 327-338.
64. Tada H, Lashgari M, Rappaport J, Khalili K (1989). Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J Virol 63: 463-466.
65. Varakis J, Zu Rhein GM, Padgett BL, Walker DL (1978). Induction of peripheral neuroblastomas in Syrian hamsters after injection of neonates with JC virus. Cancer Res 38: 1718-1722.
66. Walker DL, Padgett BL, Zu Rhein GM, Albert AE, Marsh RF (1973). Human papovavirus (JC): induction of brain tumors in hamsters. Science 181: 674-676.
67. Wegner M, Drolet DW, Rosenfeld MG (1993). Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci U S A 90: 4743-4747.